Enhanced treatment of breast cancer brain metastases with oncolytic virus expressing anti-CD47 antibody and temozolomide is a research paper published in Molecular Therapy Oncology (2024). On theSindex it has a DataRank of 0.269. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.269
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: AI129582
National Institutes of Health
Grant: CA163205
National Institutes of Health
Grant: CA265095
National Institutes of Health
Grant: CA210087
National Institutes of Health
Grant: CA223400
National Institutes of Health
Grant: CA247550
National Institutes of Health
Grant: NS106170
National Institutes of Health
Grant: CA264512
National Institutes of Health
Grant: CA266457
FWCI
1.92
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals